Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 28 Carcinoma, Non-Small-Cell Lung 28 Neoplasm Metastasis 23 Colorectal Neoplasms 19 Carcinoma, Hepatocellular 19 Triple Negative Breast Neoplasms 16 Pancreatic Neoplasms 15 Neoplasms 15 Stomach Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 13 Nasopharyngeal Carcinoma 13 Carcinoma, Renal Cell 13 Uterine Cervical Neoplasms 10 Rectal Neoplasms 10 Lymphoma 8 Sarcoma 7 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 7 Recurrence 6 Lymphoma, Extranodal NK-T-Cell 6 Lung Neoplasms 6 Locally Advanced Rectal Cancer 6 Breast Neoplasms 6 Advanced Solid Tumor 6 Ovarian Neoplasms 5 Glioblastoma 5 Endometrial Neoplasms 5 Cholangiocarcinoma 5 Small Cell Lung Carcinoma 4 Nasopharyngeal Neoplasms 4

Interventions

Diathermy 20 Radiotherapy 10 Cisplatin 5 Fluorouracil 4 Drug Therapy 4 Radiation 3 Melphalan 3 Immune Checkpoint Inhibitors 3 Cytoreduction Surgical Procedures 3 Brachytherapy 3 tislelizumab 2 Solutions 2 Immunotherapy 2 Hyperthermia, Induced 2 Hydrogen Peroxide 2 Doxorubicin 2 Conization 2 Capecitabine 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Temozolomide 1 Surgical Procedures, Operative 1 Saline Solution 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperthermia × spartalizumab × Clear all

NCT06022692 2023-09-05

HEAIS001

Zhejiang Hospital

Phase 1/2 Completed

Gastrointestinal

Hyperthermia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡